Last update 20 Mar 2025

VT-EBV-N

Overview

Basic Info

Drug Type
Gene therapy, T-lymphocyte cell therapy
Synonyms
EBV-CTL - ViGenCell, VT-EBV
Target-
Action-
Mechanism
T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication-
Inactive Indication
Extranodal NK-T-Cell LymphomaLymphoma
Originator Organization
ViGenCell, Inc.ViGenCell, Inc.
Active Organization-
Inactive Organization
ViGenCell, Inc.ViGenCell, Inc.Catholic University of KoreaCatholic University of Korea
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VT-EBV-N
NCT03671850
/ Unknown statusPhase 2
A Phase 2 Study to Evaluate the Efficacy and Safety of Postremission Therapy Using VT-EBV-N in EBV Positive Extranodal NK/T Cell Lymphoma Patients
100 Clinical Results associated with VT-EBV-N
Login to view more data
100 Translational Medicine associated with VT-EBV-N
Login to view more data
100 Patents (Medical) associated with VT-EBV-N
Login to view more data
100 Deals associated with VT-EBV-N
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Extranodal NK-T-Cell LymphomaPhase 2
South Korea
ViGenCell, Inc.ViGenCell, Inc.
16 Mar 2019
LymphomaPhase 2
South Korea
Catholic University of KoreaCatholic University of Korea
28 Jul 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free